Inovio Pharmaceuticals Inc. Stock Advances 9.9%, Outperforms Competitors

Dow Jones2025-04-15

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. rose 9.9% to $1.77 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.6% to 16,831.48 and the Dow Jones Industrial Average rising 0.8% to 40,524.79.

This was the stock's second consecutive day of gains.

Inovio Pharmaceuticals Inc. closed 86.8% short of its 52-week high of $13.44, which the company achieved on May 16th.

The stock outperformed some of its competitors, as Johnson & Johnson rose 1.7% to $154.36, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.96% to $22.12.

Trading volume totaled 801,287, compared to the 50-day average of 731,967.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

April 14, 2025 16:33 ET (20:33 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2527141866?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-15 04:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527141866","market":"us","top_or_hot":-1,"title":"Inovio Pharmaceuticals Inc. Stock Advances 9.9%, Outperforms Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Inovio Pharmaceuticals Inc. rose 9.9% to $1.77 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.6% to 16,831.48 and the Dow Jones Industrial Average rising 0.8% to 40,524.79. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Inovio Pharmaceuticals Inc. closed 86.8% short of its 52-week high of $13.44, which the company achieved on May 16th. \n</p>\n<p>\n     The stock outperformed some of its competitors, as Johnson &amp; Johnson rose 1.7% to $154.36, <a href=\"https://laohu8.com/S/STAB\">Statera Biopharma Inc</a>. remained unchanged, and Pfizer Inc. rose 0.96% to $22.12. \n</p>\n<p>\n     Trading volume totaled 801,287, compared to the 50-day average of 731,967. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 16:33 ET (20:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inovio Pharmaceuticals Inc. Stock Advances 9.9%, Outperforms Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInovio Pharmaceuticals Inc. Stock Advances 9.9%, Outperforms Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-15 04:33</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Inovio Pharmaceuticals Inc. rose 9.9% to $1.77 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.6% to 16,831.48 and the Dow Jones Industrial Average rising 0.8% to 40,524.79. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Inovio Pharmaceuticals Inc. closed 86.8% short of its 52-week high of $13.44, which the company achieved on May 16th. \n</p>\n<p>\n     The stock outperformed some of its competitors, as Johnson &amp; Johnson rose 1.7% to $154.36, <a href=\"https://laohu8.com/S/STAB\">Statera Biopharma Inc</a>. remained unchanged, and Pfizer Inc. rose 0.96% to $22.12. \n</p>\n<p>\n     Trading volume totaled 801,287, compared to the 50-day average of 731,967. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 14, 2025 16:33 ET (20:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INO","symbol_name":"伊诺维奥制药","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2527141866","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527141866","pubTimestamp":1744662780,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc. rose 9.9% to $1.77 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.6% to 16,831.48 and the Dow Jones Industrial Average rising 0.8% to 40,524.79.This was the stock's second consecutive day of gains.Inovio Pharmaceuticals Inc. closed 86.8% short of its 52-week high of $13.44, which the company achieved on May 16th.The stock outperformed some of its competitors, as Johnson & Johnson rose 1.7% to $154.36, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.96% to $22.12.Trading volume totaled 801,287, compared to the 50-day average of 731,967.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"INO":"伊诺维奥制药"},"translate_title":"Inovio Pharmaceuticals Inc.股价上涨9.9%，跑赢竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INO":1},"content_text":"This article was automatically generated by Dow Jones using technology from Automated Insights. \n\n\n     Shares of Inovio Pharmaceuticals Inc. rose 9.9% to $1.77 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.6% to 16,831.48 and the Dow Jones Industrial Average rising 0.8% to 40,524.79. \n\n\n     This was the stock's second consecutive day of gains. \n\n\n     Inovio Pharmaceuticals Inc. closed 86.8% short of its 52-week high of $13.44, which the company achieved on May 16th. \n\n\n     The stock outperformed some of its competitors, as Johnson & Johnson rose 1.7% to $154.36, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.96% to $22.12. \n\n\n     Trading volume totaled 801,287, compared to the 50-day average of 731,967. \n\n\n  Data source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 14, 2025 16:33 ET (20:33 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2527141866","isCrawlerRequest":true}